http://www.ncbi.nlm.nih.gov/pubmed/23959247
Jump Test Performance and Sarcopenia Status in Men and Women, 55 to 75 Years of Age.
Source
1Department
of Health and Exercise Science, University of Oklahoma, Norman.
2University of Oklahoma Health Sciences Center, Oklahoma City.
Abstract
BACKGROUND AND PURPOSE::
Jumping
mechanography uses maximal countermovement jumps to test obtain such as
jump power (JPow). Recently, it has been shown to be a safe method for
assessing muscle function in older adults; however, little is known
about the relationships between JPow, muscle strength, and sarcopenia status. The purpose of this study was to examine jump performance, muscle strength, and sarcopenia status in older adults.
METHODS::
This
was a cross-sectional study that included men (n = 27) and women (n =
33) (55-75 years) recruited from the general community. Participants
completed health status and physical activity questionnaires. Body
composition, including appendicular skeletal muscle mass (ASM), bone
free lean body mass, and relative skeletal muscle mass index, were
assessed by total body dual-energy x-ray absorptiometry scans. The
criteria for sarcopenia
were relative skeletal muscle mass index values less than 7.26 kg/m for
men and less than 5.45 kg/m for women. Three vertical jumps on a jump
mat were performed to assess JPow, jump velocity (JVel), and jump height
(JHt). Muscle strength was measured by 1RM testing for leg press (LP)
and right and left hip abduction isotonic resistance exercises.
RESULTS::
Sarcopenia was found in 20% (12/60) of the participants. Jump power was significantly lower (P= .001) in the sarcopenia
group than in the normal group, 651.1 (41.7) W versus 851.0 (27.4) W,
respectively. Jump power and JHt were significantly (P< .01)
positively correlated (r= 0.54-0.77) with ASM and bone free lean body
mass. Significant (P< .01) positive correlations (r= 0.43-0.70) were
also reported between jump test variables (JPow, JVel, JHt) and muscle
strength (LP, right and left hip abduction).
DISCUSSION::
The
jump test protocol was conducted safely with no injuries or balance
issues. Our finding of lower JPow in sarcopenic individuals adds new
information to the existing literature on age-related declines in muscle
power.
CONCLUSION::
Community-dwelling individuals
classified as sarcopenic had significantly lower JPow but not muscle
strength compared with their counterparts with normal amounts of muscle
mass. Jump test variables were positively correlated with lean tissue
and lower body muscle strength. Based on our findings, JPow may be
useful for sarcopenia
screening in the middle-aged and older adults; however, more research
is needed to determine the utility of this method in clinical
populations.
No comments:
Post a Comment